G. Duginski
Papers
1
Total Citations
3
H-Index
1
About
G. Duginski is a rising figure in the field of regenerative medicine, with a focused expertise in the scalable and reproducible manufacturing of mesenchymal stromal cells (MSCs). Their primary research centers on the critical challenge of translating MSC-based therapies from the lab to the clinic by addressing the notorious variability in cell fabrication. Duginski’s major contribution lies in pioneering the integration of automation and performance-based selection into the MSC production pipeline. This work directly tackles the bottleneck of batch-to-batch inconsistency, aiming to standardize cell quality and potency. Their most-cited paper, "Automation and Performance-Based Selection to Improve the Reproducibility of Mesenchymal Stromal Cell (MSC) Fabrication" (2024, 3 citations), serves as a foundational blueprint for this approach, proposing a shift from traditional, manual methods to a more robust, data-driven manufacturing paradigm. While early in their career, Duginski’s work is already influencing discussions on regulatory compliance and industrial-scale cell therapy production, marking them as a key contributor to the future of reliable, off-the-shelf cellular therapeutics.
Research Focus
Key Achievements
Top Papers
- 1